Pro-Dex, Inc. (PDEX) financial statements and ratios from SEC XBRL: revenue $66.59M (TTM), net margin 13.5%, revenue growth 14.6% YoY, P/E 17.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $66.59M |
| Net Margin | 13.5% |
| Revenue Growth (YoY) | 14.6% |
| EPS Growth (YoY) | 23.0% |
| FCF Growth (YoY) | 165.0% |
| P/E Ratio | 17.6 |
| EV / EBITDA | 16.2 |
| Price / Book | 4.66 |
| Price / Sales | 2.82 |
| FCF Yield | 3.4% |
| DCF Value (model) | $45.91 |
| DCF Upside vs Price | -30.5% |
| Altman Z-Score | 8.39 (safe) |
| Piotroski F-Score | 6/9 |
| Sector P/E (Healthcare) | 21.6 |
PDEX overview · PDEX earnings · PDEX KPIs · PDEX investor relations · PDEX ownership · PDEX peers · PDEX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.